Company intelligence / Profile preview

Live Collagen

Ownership: Private
Development stage: Other

Overview

Live Collagen is a biotechnology company specializing in the development and commercialization of high-purity, bioactive collagen products derived from sustainable sources. The company's proprietary technology preserves the natural triple-helix structure of collagen, ensuring maximum biological activity and efficacy for medical and aesthetic applications. Their product portfolio targets wound care, regenerative medicine, and advanced skincare, providing clinicians and consumers with superior alternatives to traditional processed collagen. By maintaining the "live" state of the protein, the company aims to accelerate tissue repair and improve patient outcomes across various therapeutic areas.

Therapeutic areas: OtherDermatology
Modalities: ProteinBiologic
Industry: Biotech

Beyond the preview

Go deeper on Live Collagen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Live Collagen.

Explore the full profile